Overview Fundamentals API Earnings EOD API Sample Code Pricing

89bio Inc (ETNB NASDAQ) stock market data APIs

$9.85 0.61(6.6%) as of July 26, 2024
Price chart is built with Anychart

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis; and for the treatment of severe hypertriglyceridemia. The company was incorporated in 2018 and is headquartered in San Francisco, California.

89bio Inc Financial Data Overview

9.24
9.85
-
9.85
9.19
6.575-18.3
950 M
98 384 K
0
-0.54
0.998
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ETNB',
Type: 'Common Stock',
Name: '89bio Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00QKDZ8J5',
ISIN: NULL,
CUSIP: NULL,
CIK: '1785173',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2019-11-11',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

89bio Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -179 912 000
  • Earnings Per Share -2
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get 89bio Inc Earnings via APIs

  • Latest Release 2024-05-09
  • EPS/Forecast -0.46

Get 89bio Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com